<DOC>
	<DOCNO>NCT03091218</DOCNO>
	<brief_summary>This prospective registry study surveil early liver injury cause Runzao Zhiyang Capsule ( RZZY Capsule ) non-intervention observational way . And attempt establish predictive model screen susceptibility RZZY Capsule .</brief_summary>
	<brief_title>Surveillance Early Liver Injuries Caused Runzao Zhiyang Capsule .</brief_title>
	<detailed_description>The primary objective study include : ( ) The detection patient serum liver biochemistry abnormality less 8 week intake RZZY Capsule ; ( ii ) The record overall individual demographic , underlie disease , physical status , medication information , clinical laboratory index , ; ( iii ) The specimen collection surveil individual . ( iv ) The attempt establish predictive model screen susceptibility RZZY Capsule .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Drug-Induced Liver Injury</mesh_term>
	<criteria>1 . Individuals accordance indication RZZY Capsule , include skin pruritus , acne vulgaris constipation ; 2 . The age range 18 70 years； 3 . Individuals take RZZY Capsule 2 week ; 4 . Abnormalities serum biochemistry achieve one criterion follow : ( ) alanine aminotransaminase ( ALT ) aspartate transaminase ( AST ) ≥2 fold upper limit normal ( ULN ) ; ( ii ) total bilirubin ( TBiL ) ≥ 2 ULN ; ( iii ) alkaline phosphatase ( ALP ) ≥ 2 ULN ; 5 . Individuals provide inform consent form . 1 . Individuals without indication RZZY Capsule ; 2 . Unconformity RZZY Capsule drug label ; 3 . Individual take RZZY Capsule less 2 week ; 4 . Individuals take hepatotoxic drug combine RZZY Capsule , simultaneously ; 5 . Unconformity diagnostic standard herbinduced liver injury ( Guideline Diagnosis Treatment Herbinduced Liver Injury , RPGIP2016CN003） .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Drug-Induced Liver Injury</keyword>
</DOC>